Annual Retained Earnings
-$253.15 M
-$30.15 M-13.52%
31 December 2023
Summary:
NRx Pharmaceuticals annual retained earnings is currently -$253.15 million, with the most recent change of -$30.15 million (-13.52%) on 31 December 2023. During the last 3 years, it has fallen by -$162.97 million (-180.71%). NRXPW annual retained earnings is now -68611.62% below its all-time high of $369.50 thousand, reached on 31 December 2019.NRXPW Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$269.19 M
-$1.62 M-0.61%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly retained earnings is currently -$269.19 million, with the most recent change of -$1.62 million (-0.61%) on 30 September 2024. Over the past year, it has dropped by -$20.38 million (-8.19%). NRXPW quarterly retained earnings is now -41984.04% below its all-time high of $642.72 thousand, reached on 31 March 2020.NRXPW Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.5% | -8.2% |
| 3 y3 years | -180.7% | -76.6% |
| 5 y5 years | - | -10000.0% |
NRXPW Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -180.7% | at low | -76.6% | at low |
| 5 y | 5 years | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
NRx Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$269.19 M(+0.6%) |
| June 2024 | - | -$267.57 M(+3.0%) |
| Mar 2024 | - | -$259.68 M(+2.6%) |
| Dec 2023 | -$253.15 M(+13.5%) | -$253.15 M(+1.7%) |
| Sept 2023 | - | -$248.81 M(+22.2%) |
| Dec 2022 | -$223.00 M(+21.7%) | - |
| June 2022 | - | -$203.67 M(+3.5%) |
| Mar 2022 | - | -$196.69 M(+7.3%) |
| Dec 2021 | -$183.24 M | -$183.24 M(+20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$152.45 M(+15.8%) |
| June 2021 | - | -$131.68 M(>+9900.0%) |
| Dec 2020 | -$90.18 M(<-9900.0%) | -$64.92(<-9900.0%) |
| Sept 2020 | - | $0.37(-100.0%) |
| June 2020 | - | $493.21 K(-23.3%) |
| Mar 2020 | - | $642.72 K(+73.9%) |
| Dec 2019 | $369.50 K | $369.50 K(-3.8%) |
| Sept 2019 | - | $384.25 K(+18.2%) |
| June 2019 | - | $325.05 K(+118.1%) |
| Mar 2019 | - | $149.03 K |
FAQ
- What is NRx Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual retained earnings year-on-year change?
- What is NRx Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly retained earnings year-on-year change?
What is NRx Pharmaceuticals annual retained earnings?
The current annual retained earnings of NRXPW is -$253.15 M
What is the all time high annual retained earnings for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual retained earnings is $369.50 K
What is NRx Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, NRXPW annual retained earnings has changed by -$30.15 M (-13.52%)
What is NRx Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of NRXPW is -$269.19 M
What is the all time high quarterly retained earnings for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly retained earnings is $642.72 K
What is NRx Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, NRXPW quarterly retained earnings has changed by -$20.38 M (-8.19%)